A detailed history of Resurgent Financial Advisors LLC transactions in Medtronic PLC stock. As of the latest transaction made, Resurgent Financial Advisors LLC holds 5,186 shares of MDT stock, worth $439,461. This represents 0.27% of its overall portfolio holdings.

Number of Shares
5,186
Previous 6,219 16.61%
Holding current value
$439,461
Previous $489,000 4.7%
% of portfolio
0.27%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.84 - $91.03 $79,375 - $94,033
-1,033 Reduced 16.61%
5,186 $466,000
Q2 2024

Aug 14, 2024

SELL
$78.71 - $87.02 $198,034 - $218,942
-2,516 Reduced 28.8%
6,219 $489,000
Q1 2024

May 10, 2024

BUY
$82.84 - $88.09 $269,727 - $286,821
3,256 Added 59.43%
8,735 $761,000
Q4 2023

Feb 09, 2024

BUY
$69.43 - $83.43 $101,090 - $121,474
1,456 Added 36.19%
5,479 $451,000
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $27,220 - $31,459
348 Added 9.47%
4,023 $315,000
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $61,827 - $71,093
-778 Reduced 17.47%
3,675 $323,000
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $31,378 - $35,820
-409 Reduced 8.41%
4,453 $359,000
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $17,292 - $19,916
-227 Reduced 4.46%
4,862 $377,000
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $324,938 - $383,527
-4,024 Reduced 44.16%
5,089 $411,000
Q2 2022

Aug 15, 2022

SELL
$87.4 - $113.09 $490,663 - $634,887
-5,614 Reduced 38.12%
9,113 $818,000
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $227,713 - $254,428
2,264 Added 18.17%
14,727 $1.63 Million
Q4 2021

May 16, 2022

BUY
$99.53 - $127.75 $1.24 Million - $1.59 Million
12,463 New
12,463 $1.29 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Resurgent Financial Advisors LLC Portfolio

Follow Resurgent Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resurgent Financial Advisors LLC with notifications on news.